clinical evaluation

clinical evaluation

Medtalk An evaluation of whether a Pt has symptoms of a disease, is responding to treatment, or is having adverse reactions to therapy
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
The CE-marked BGM Galectin-3 test is marketed in Europe to help determine the prognosis of patients diagnosed with acute and chronic heart failure when used in combination with clinical evaluation. The product is also CE-marked to help the assessment of the risk of new onset heart failure in adults.
BG Medicine unveils positive clinical data for BGM Galectin-3 test in heart failure patients
M2 EQUITYBITES-August 6, 2013-ViroPharma to cancel Phase II clinical evaluation of subcutaneous Cinryze(C)2013 M2 COMMUNICATIONS http://www.m2.com
ViroPharma to cancel Phase II clinical evaluation of subcutaneous Cinryze
Among the topics are the evolution of concepts in flexor tendon surgery of the hand, frozen shoulder, the biomechanical and clinical evaluation of tendons and ligaments, and tissue engineering strategies for the regeneration of the anterior cruciate ligament.
Repair and Regeneration of Ligaments, Tendons, and Joint Capsule
The company added the IRB approval enables the commencement of a clinical evaluation of Symphony that will support its CE Mark Technical File.
Echo Therapeutics Inc wins IRB's approval to commence clinical trial of Symphony CGM System
PPI-668 is the company's second NS5A inhibitor to progress to clinical testing after Phase 1 clinical evaluation of PPI-461.
Presidio Pharmaceuticals unveils results from Phase 1a-1b clinical trial of PPI-668
The company said that these clinical trials include patients presenting to the emergency department with chest pain and undergoing clinical evaluation including the performance of Positron Emission Tomography coupled to Computerized Axial Tomography (PET/CT) to detect the presence or absence of myocardial ischemia (523 patients enrolled), patients presenting with stroke symptoms (850 patients enrolled) and in trauma patients including traumatic brain injury where we already published favourable results (more than 3500 patients enrolled).
Ampio announces completion of patient enrolment for Its Oxidation Reduction Potential (ORP) clinical trials
The Swiss company said that GVXN SD133 is its first product to enter clinical evaluation.
GlycoVaxyn initiates clinical trial of GVXN SD133 for Shigella dysenteriae
Psoriasis has been selected by Idera as the initial indication for the first clinical evaluation of IMO-3100 in patients with autoimmune disease.
FDA approves Phase II trial of Idera's IMO-3100 in psoriasis patients
Leading European Union centres began initial clinical evaluation of the Trevo System following receipt of the CE Mark in late 2009.
Concentric Medical Inc secures regulatory approval for Trevo System in Canada and Europe
Presidio plans to launch early clinical development Phase Ib and Phase IIa of its novel HCV NS5A inhibitors, with subsequent Phase II-III clinical evaluation of such NS5A candidates in suitable combination regimens with other HCV antivirals through corporate partnering or intercompany collaborations.
Presidio Pharmaceuticals unveils positive data from HCV antiviral programme
Leading EU centers began initial clinical evaluation of the Trevo System following receipt of CE Mark in late 2009.
Concentric Medical receives approval for Trevo System in Europe, Canada

Medical browser ?
Full browser ?